A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine

Influenza A (H7N9) emerged earlier this year as a health threat in China. Efforts to develop a vaccine are under way. This letter presents initial phase 1 clinical data on the safety and immunogenicity of a candidate vaccine.